COMPARISON BETWEEN THE ACUTE HEMODYNAMIC EFFECTS AND BRAIN PENETRATION OF ATENOLOL AND METOPROLOL

被引:57
作者
VANZWIETEN, PA
TIMMERMANS, PBMWM
机构
[1] Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, Amsterdam
关键词
Acute hemodynamic effects; Atenolol; Brain penetration; Metoprolol;
D O I
10.1097/00005344-197901000-00009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atenolol and metoprolol are β1-selective adrenergic receptor blockers, devoid of local anesthetic and intrinsic sympathomimetic properties. Their antihypertensive and hypotensive activities are equivalent. They differ with respect to their lipophilic character, as is apparent from their octanol/buffer (pH. 7.4 at 37°C) partition coefficients: metoprolol. 1.084; atenolol, 0.012. We compared the two agents with regard to their acute hemodynamic effects and degree of penetration into the cerebrospinal fluid (CSF) and into the brain. For this purpose [3H]-metoprolol and [14C]-atenolol were injected either intravenously or into the left vertebral artery of chloralose-anesthetized cats. With both routes of administration, metoprolol, the more lipophilic of the two compounds, achieved much higher concentrations in the CSF and in the pontomedullary region than did atenolol. One hour after completion of an intravenous injection, the concentration of metoprolol in the CSF was about 6.5 times higher than that of atenolol; after administration into the vertebral artery, the difference was about ninefold. In spite of these considerable differences, the hypotensive and bradycardic activities of both drugs, administered intravenously or into the left vertebral artery, were virtually the same. These results suggest that the acute hemodynamic effects of metoprolol and atenolol are probably not due to an action within the central nervous system, but rather to a peripheral mechanism. © 1979 Raven Press, New York.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 14 条
[1]  
ABLAD B, 1975, ACTA PHARMACOL TOXIC, V36, P1
[2]  
BARRETT AM, 1977, POSTGRAD MED J, V53, P58
[3]  
BORG KO, 1975, ACTA PHARMACOL TOX, V36, P125
[4]   METOPROLOL - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION AND ANGINA-PECTORIS [J].
BROGDEN, RN ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1977, 14 (05) :321-348
[5]  
BROWN HC, 1976, CLIN PHARMACOL THER, V20, P524
[6]   CENTRAL HYPOTENSIVE EFFECT OF ALPHA-METHYLDOPA [J].
HENNING, M ;
VANZWIET.PA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1968, 20 (06) :409-&
[7]   COMPARATIVE STUDIES ON CENTRAL FACTORS CONTRIBUTING TO HYPOTENSIVE ACTION OF PROPRANOLOL, ALPRENOLOL, AND THEIR ENANTIOMERS [J].
OFFERHAUS, L ;
VANZWIET.PA .
CARDIOVASCULAR RESEARCH, 1974, 8 (04) :488-495
[8]   PHARMACOKINETIC STUDIES ON SELECTIVE BETA-1-RECEPTOR ANTAGONIST METOPROLOL IN MAN [J].
REGARDH, CG ;
BORG, KO ;
JOHANSSON, R ;
JOHNSSON, G ;
PALMER, L .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (04) :347-364
[9]  
REID JL, 1974, J PHARMACOL EXP THER, V188, P394
[10]   GAS-CHROMATOGRAPHIC DETERMINATION OF ATENOLOL IN BIOLOGICAL SAMPLES [J].
SCALES, B ;
COPSEY, PB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (06) :430-433